Further studies have identified IL-33 as key mediator of hepatic fibrosis by demonstrating that IL-33 deficiency ameliorates liver fibrosis induced by bile duct ligation and carbon tetrachloride (CCl4) (McHedlidze et al., 2013). The gene discussed is IL33; the disease is Hepatic fibrosis.